Manning & Napier Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Manning & Napier Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$763K	Sell	1,553 -4,831	-76%	-$2.62M	0.01%	255
2025 Q4	$3.72M	Sell	6,384 -284,512	-98%	-$161M	0.05%	165
2025 Q3	$141M	Sell	290,896 -21,457	-7%	-$9.99M	1.8%	15
2025 Q2	$127M	Sell	312,353 -50,758	-14%	-$21.2M	1.51%	23
2025 Q1	$181M	Buy	363,111 +95,509	+36%	+$51.7M	2.23%	11
2024 Q4	$139M	Buy	267,602 +73,575	+38%	+$40.5M	1.59%	19
2024 Q3	$120M	Buy	194,027 +52,498	+37%	+$31.1M	1.32%	24
2024 Q2	$78.3M	Buy	+141,529	New	+$81.1M	0.88%	40
2017 Q3	$32.4M	Sell	171,095 -100,615	-37%	-$18.2M	0.28%	66
2017 Q2	$47.4M	Sell	271,710 -55,793	-17%	-$9.37M	0.41%	57
2017 Q1	$50.3M	Sell	327,503 -87,708	-21%	-$13.4M	0.39%	52
2016 Q4	$58.6M	Buy	415,211 +1,670	+0.4%	+$246K	0.38%	57
2016 Q3	$65.8M	Sell	413,541 -217,799	-34%	-$33.6M	0.4%	52
2016 Q2	$93.3M	Sell	631,340 -56,550	-8%	-$8.35M	0.57%	52
2016 Q1	$97.4M	Buy	687,890 +102,380	+17%	+$13.7M	0.56%	51
2015 Q4	$83.1M	Buy	585,510 +81,130	+16%	+$10.8M	0.48%	55
2015 Q3	$61.7M	Buy	+504,380	New	+$65.7M	0.33%	66

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Manning & Napier Advisors's TMO Position: Q1 2026 in Review

Manning & Napier Advisors reduced its Thermo Fisher Scientific (TMO) stake by 76% in Q1 2026, selling an estimated $2.62M and leaving 1,553 shares worth $763K. The position accounts for 0.01% of the portfolio, ranked #255.

Manning & Napier Advisors first reported a position in TMO in Q3 2015 and has held it in 17 quarters since. The position peaked at $181M in Q1 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Manning & Napier Advisors held 1,553 shares of Thermo Fisher Scientific worth $763K as of Q1 2026.
Manning & Napier Advisors sold 4,831 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.62M.
Thermo Fisher Scientific made up 0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #255 holding.
Manning & Napier Advisors first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 17 quarters since.
Manning & Napier Advisors's Thermo Fisher Scientific position peaked at $181M in Q1 2025.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.